Roche soars in Q3, carried by Covid-19 test demand
Third quarter Roche sales figures exceeded analysts' expectations. Sales in the Roche Group totaled almost CHF 16bn (USD 17.3) in Q3, whereas sales in the diagnostics division amounted to CHF 4.26bn (USD 4.6bn).
BY MARKETWIRE, TRANSLATED BY DANIEL PEDERSEN
Swiss pharmaceutical giant Roche has ended the year's third quarter looking better than anticipated by analysts, reports Bloomberg News, which has collected a consensus estimate.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
